pelvic tumors
Conditions
Interventions
trial group:using 3D printing prosthesis to reconstruct the limb
control group:using traditional half pelvic prosthesis to reconstruct the limb
Sponsors
Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
16 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. 16 years of age or older, and our citizens under the age of 85 years; 2. platelets above 50000, blood sugar is not higher than 10.0, white blood cells no less than 4.0 x10^9/L, good nutritional status; 3. hepatitis a, hepatitis b, hepatitis c, HIV/AIDS, tuberculosis and other infectious diseases are not in the activity stage; 4. primary pelvic bone tumors without metastasis, or only single metastases; 5. single pelvic metastase , and the primary focal disease can be effectively controlled. 6. involving the hip malignant tumor limb-salvage excision need function reconstruction; 7. no implant contraindication; 8. postoperative survival above 2 years or more; 9. do not attend any clinical validation within three months; 10. agreed to participate in the test, understand and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. any active systemic and local infection; 2. poor general condition, severe malnutrition or cachexia, poor blood sugar control. 3. multi-bone metastases; 4. multiple bone metastases, or primary focal disease too severe to be effectively treated; 5. defects of bone and soft tissue involvement heavily influence the implant stability; 6. allergic to the material; 7. estimated lifetime is not more than two years; 8. not timely follow-up, or for other reasons can't cooperate with researchers; 9. can not accepte the new technology.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MSTS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| surgery time;Intraoperative blood transfusion volume;Intraoperative and postoperative complications;remission of tumor symptoms after surgery;Imaging findings; | — |
Countries
China
Contacts
Public ContactYongqiang Hao
Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed